COVID Vaccine

WebinarsCOVID Vaccine ResourcesVaccine DeploymentVaccine Administration, Handling, and BillingPatient Information


APA COVID-19 Vaccine Communication Toolkit - Click here to download full toolkit
On January 18, Phase 1B started in Arkansas and 440,000 Arkansans were added to the list of eligible individuals for the COVID-19 vaccine. Supply of the vaccine continues to be constrained (and will be for the foreseeable future) which has already led to higher foot traffic and call volume by vaccine seekers. APA is providing this communications toolkit for pharmacists to use to help communicate to the public about the vaccine and to help alleviate some of the enormous pressure pharmacists are under. The toolkit includes:

Breaking News Update - May 12, 2021 - FDA, CDC, and ACIP Authorize Pfizer COVID-19 Vaccine for Use in Adolescents Ages 12-15
FDA, CDC, and ACIP have all authorized the Pfizer COVID-19 vaccine for use in adolescents ages 12-15. While the Pfizer vaccine is now authorized for ages 12 and up, the Moderna and Johnson & Johnson vaccines are currently only authorized for ages 18 and up.

Update - March 30, 2021 - Governor Hutchinson Opens COVID Vaccination to All Arkansans Ages 16+
On Tuesday, March 30, Governor Asa Hutchinson moved Arkansas into Phase 2, making any Arkansan ages 16 and over eligible to receive the COVID-19 vaccine. Note: The Pfizer vaccine is currently the only COVID-19 vaccine approved for ages 16 and over. Moderna and Johnson & Johnson is approved for ages 18 and over.

Webinars

 


COVID Vaccine Resources

Vaccine Deployment
Vaccine Administration, Handling, and Billing



Patient Information